Ignite Creation Date:
2025-12-24 @ 10:46 PM
Ignite Modification Date:
2026-06-23 @ 12:36 AM
Study NCT ID:
NCT06271369
Status:
COMPLETED
Last Update Posted:
2024-02-21
First Post:
2024-02-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Real-World HRU and Costs in DLBCL Pts With Tisa-cel and Axi-cel, a Medicare Study.
Sponsor:
Novartis Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Diffuse Large B-cell Lymphoma | View |
Keywords: